CGRP receptor antagonists

Details for Australian Patent Application No. 2004230926 (hide)

Owner Merck & Co., Inc.

Inventors Nguyen, Diem N.; Williams, Theresa M.; Paone, Daniel V.; Deng, Zhengwu J.; Shaw, Anthony W.; Burgey, Christopher S.

Agent Spruson & Ferguson

Pub. Number AU-B-2004230926

PCT Pub. Number WO2004/092166

Priority 60/510,352 10.10.03 US; 60/463,089 15.04.03 US

Filing date 9 April 2004

Wipo publication date 28 October 2004

Acceptance publication date 17 July 2008

International Classifications

C07D 471/00 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4188 (2006.01)

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/092166 Priority application(s): WO2004/092166

17 July 2008 Application Accepted

  Published as AU-B-2004230926

13 November 2008 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004230927-Polymeric oligonucleotide prodrugs

2004230923-Fragrance compositions comprising benzo(4,5)thieno(3,2-b)pyran-2-one